Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 5/24/2012
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.00 | 0.00 | 0.00 |
| EPS, GAAP | 0.00 | 0.00 | 0.00 |
| Consensus Estimate | 0.00 | 0.00 | 0.00 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 0.00 | 0.00 | 0.00 |
| EPS, GAAP | 0.00 | 0.00 | 0.00 |
| Consensus Estimate | 0.00 | 0.00 | 0.00 |
| TEVA | Industry Average | |
| P/E (TTM) | 12.47 | NA |
| P/E (Forward) | 0.00 | NA |
| PEG Ratio | 0.00 | 0.00 |
| Price/Sales | 0.00 | 0.00 |
| Beta | 0.00 | 0.00 |
| 9:22 AM | 5/24/2012 | Teva Pharma Reduces 2012 Guidance On Lower Generics View |
| 3:39 PM | 5/17/2012 | UPDATE:FDA Approves Generic Versions Of Blood-Thinning Drug Plavix |
| 5/24/2012 | Teva Rising Despite Guidance Cuts (Barrons.com) |
| 5/24/2012 | Updates, advisories and surprises (MarketWatch.com) |
| 5/18/2012 | A.M. Vitals: FDA OKs Generic Plavix (WSJ.com) |
| 5/17/2012 | FDA Approves Generic Versions of Plavix (WSJ.com) |
| 5/10/2012 | 24/7 Wall St. Closing Bell (ORCL, NOV, MMM, TEVA, JDSU, AMCX, MT, HNR, KSS, WIN, DDS, JKS, PGR, SOL, URRE, MNST, WFR) (24/7 Wall St) |
| 5/10/2012 | Top Analyst Upgrades & Downgrades (ARMH, BIG, CHKM, CSCO, CPWM, DLB, HGSI, JDSU, LINE, MMM, NOV, ORCL, RGP, TPX, TLLP, TEVA, VRTX) (24/7 Wall St) |
| 5/8/2012 | Teva Is Easy Pill to Swallow (WSJ.com) |
| 5/1/2012 | Building a Global Brand in Generic Drugs (Barrons.com) |
![[sm061210things]](http://s.wsj.net/public/resources/images/PF-AC562_sm0612_C_20120514113337.jpg)
![[sm0612wedding4]](http://s.wsj.net/public/resources/images/PF-AC579_sm0612_C_20120515172853.jpg)
![[sm0612strat]](http://s.wsj.net/public/resources/images/PF-AC580_sm0612_C_20120515180019.jpg)
![[sm0612roi]](http://s.wsj.net/public/resources/images/PF-AC573_sm0612_C_20120515125902.jpg)
